It is clinically relevant to consider the organ distribution and abundance of ACE2 and co-factor transmembrane serine protease 2 (TMPRSS2) with age and sex and how COVID-19 affects enzyme activity and subsequently peptide products ANGII and Ang1–7. Here, ACE2 is linked to COVID-19.